PHENOMIX SCIENCES, INC. – Trademark Portfolio
Entity Type: 03
PHENOMIX SCIENCES, INC. holds 12 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 12 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 9 trademarks are registered and 1 is pending. Notable registered marks include PSIOP, PHENOMIX, MYPHENOME, PHENODIET, and SLOW BURN. The owner is based in MENLO PARK, CA.
3000 SAND HILL ROAD
SUITE 3-210
MENLO PARK, CA 94025
Showing of trademarks Trademarks
Trademark Classifications
PHENOMIX SCIENCES, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does PHENOMIX SCIENCES, INC. have?
PHENOMIX SCIENCES, INC. has 12 U.S. trademarks filed with the USPTO. Of these, 9 registered, 1 pending, 2 abandoned.
What trademark classes does PHENOMIX SCIENCES, INC. file in?
PHENOMIX SCIENCES, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 42 (Computer & Scientific). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are PHENOMIX SCIENCES, INC.'s most well-known trademarks?
PHENOMIX SCIENCES, INC.'s registered trademark portfolio includes well-known marks such as PSIOP, PHENOMIX, MYPHENOME, PHENODIET, and SLOW BURN. These are among 9 currently registered trademarks in the portfolio.
What is PHENOMIX SCIENCES, INC.'s trademark registration success rate?
PHENOMIX SCIENCES, INC. has a 82% trademark registration rate, with 9 out of 11 resolved applications resulting in successful registration. Currently, 1 application is pending review.